Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Identification of Key Blood Molecular Markers for Immunotherapy
| Conditions: | Carcinomas (Including Squamous Cell and Adenocarcinoma)|Anal Cancer|Bile Duct Cancer (Cholangiocarcinoma)|Bladder (Urothelial, Transitional Cell) Cancer|Blood and Marrow Transplant (BMT)|Bone Cancer|Brain (Nervous System) Cancers|Breast Cancer|Colon/Recta |
| Start Date: | July 1, 2006 |
| Phase: | |
| Status: | Recruiting |
| NCT ID: | NCT00507702 |
| Study Type: | Observational |
| Intervention: | Procedure: phlebotomy |
| Study Design: | Observational Model: Cohort|Time Perspective: Prospective |
| Results: | No Results Available |
| Sponsors: | Stanford University |
| Ages: | Adult|Senior |
| Enrollment: | 300 |
| Funded By: | Other |
| First Received: | July 24, 2007 |
| End Date: | July 1, 2010 |
| Last Updated: | August 19, 2010 |
| Last Verified: | August 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
